108
Participants
Start Date
June 20, 2018
Primary Completion Date
July 25, 2019
Study Completion Date
July 25, 2019
Bryostatin
The investigational drug product, bryostatin, is a sterile, pyrogen-free, lyophilized powder intended for IV infusion upon reconstitution and dilution.
Placebo
The placebo is a sterile, pyrogen-free, lyophilized powder identical in appearance to the experimental drug
Burke Rehabilitation Hospital, White Plains
Neurological Associates of Albany, PC, Albany
Alzheimer's Memory Center, Charlotte
Atlanta Center for Medical Research, Atlanta
Medical Research & Health Education Foundation, Columbus
Bioclinica Research, The Villages
Anchor Neuroscience, Pensacola
Medical Research Group of Central Florida, Orange City
Bioclinica Research, Orlando
MD Clinical, Hallandale
Miami Jewish Health / Stein Gerontological Institute, Miami
Phoenix Medical Research, Miami
Miami Dade Medical Research Institute, LLC, Miami
Brain Matters Research, Delray Beach
Alzheimer's Research and Treatment Center, Lake Worth
JEM Research, Atlantis
Stedman Clinical Trials, Tampa
Insight Clinical Trials, LLC, Shaker Heights
Alexian Brothers Neuroscience Institute, Elk Grove Village
Millennium Psychiatric Associates, Creve Coeur
Lake Charles Clinical Trials, Lake Charles
Nader Pharmacology Research Institute, Los Alamitos
Syrentis Clinical Research, Santa Ana
Southern California Research, LLC, Simi Valley
Neuro Pain Medical Center, Fresno
Memory Health Center at Summit Research Network, Portland
Alzheimer's Disease Center, Quincy
The Cognitive and Research Center of New Jersey, Springfield
Lead Sponsor
Collaborators (1)
Worldwide Clinical Trials
OTHER
Neurotrope Bioscience, Inc.
INDUSTRY